Healthcare -
Biotechnology - NASDAQ - US
$ 6.7
-8.34 %
$ 70.1 M
Market Cap
0.07
P/E
AVTX - TAX PROVISION
Tax Provision AVTX - Avalo Therapeutics, Inc.
14 K
LAST VALUE
43.92%
2 YEAR CAGR
19.26%
5 YEAR CAGR
-18.67%
10 YEAR CAGR